Goldman Sachs analyst David Roman initiated coverage of Doximity (DOCS) with a Neutral rating and $58 price target The firm has a constructive ...

Doximity's Q2 earnings showed impressive revenue growth and margin expansion. Check out my price target for DOCS stock and ...

The online medical platform reported quarterly revenue of $136.8 million and earnings of 30 cents a share, beating analysts ...

In a report released today, Jailendra Singh from Truist Financial assigned a Hold rating to Doximity (DOCS – Research Report). The ...

Shares of Doximity (NYSE: DOCS) rocketed 35% higher as of 1:45 p.m. ET Friday, according to data provided by S&P Global ...

Doximity's fiscal 2025 Q2 earnings beat analyst and management expectations despite ongoing macroeconomic uncertainties in ...

In the last three months, 9 analysts have published ratings on Doximity DOCS, offering a diverse range of perspectives from ...

Healthcare professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street’s expectations in Q3 CY2024, with sales up 20.4% year on year to $136.8 million. On top of that, next quarter ...

On Thursday, Doximity Inc (DOCS) stock saw a modest uptick, ending the day at $43.42 which represents a slight increase of $1.07 or 2.53% from the prior close of $42.35. The stock opened at $42.41 and ...

Doximity shares surged after the health-care provider social network posted fiscal second-quarter earnings and revenue ahead of Wall Street expectations. Shares of Doximity shot up 44% to $62.51 ...

Doximity (NYSE:DOCS) is on fire. The stock exploded 37% Friday after the online medical platform smashed earnings expectations for fiscal Q2 2025. Revenue hit $136.8 millionup 20% year-over ...